FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
Stifel analyst Daniel Arias lowered the price target on Exact Sciences (NASDAQ: EXAS) to $125.00 (from $145.00) while maintaining a Buy rating.
The analyst commented, "EXAS's 3Q saw the company miss on Screening (Cologuard) revenues, and lower the outlook for 4Q - as... More


